A novel small molecular NADPH oxidase 2 (Nox2) inhibitor GSK2795039 has also been demonstrated to prevent RIP1-RIP3-MLKL-mediated cardiomyocyte necroptosis, improving myocardial remodeling and function in ADR-induced heart failure [45]. The gene discussed is CYBB; the disease is heart failure.